Using Remdesivir and Dexamethasone for Treatment of SARS-CoV-2 Shortens the patient's stay in the Hospital
AA Dawood - Asian Journal of Pharmaceutical Research, 2021 - indianjournals.com
Asian Journal of Pharmaceutical Research, 2021•indianjournals.com
… Later and according to preliminary clinical findings shared between the World Health
Organization and the United Kingdom, dexamethasone could be lifesaving for critical
patients with SARS-CoV-2. Dexamethasone was the assessment by the FDA on 16th June
2020 for the treatment coronavirus. It was found that treatment reduces deaths by one-third
of patients who use ventilators, while the percentage decreased to one fifth for patients who
only required oxygen. This benefit was observed only in severe cases of …
Organization and the United Kingdom, dexamethasone could be lifesaving for critical
patients with SARS-CoV-2. Dexamethasone was the assessment by the FDA on 16th June
2020 for the treatment coronavirus. It was found that treatment reduces deaths by one-third
of patients who use ventilators, while the percentage decreased to one fifth for patients who
only required oxygen. This benefit was observed only in severe cases of …
With several setbacks, scientists continue to pursue an appropriate medicine or vaccine in order to combat the current epidemic. At one point, the use of combination medications is possibly just the correct way to find successful coronavirus therapy.
indianjournals.com
以上显示的是最相近的搜索结果。 查看全部搜索结果